We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Bachem Holding AG (BANB) CHF0.05

Sell:680.00 CHF Buy:696.00 CHF Change: 19.00 CHF (2.87%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:680.00 CHF
Buy:696.00 CHF
Change: 19.00 CHF (2.87%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:680.00 CHF
Buy:696.00 CHF
Change: 19.00 CHF (2.87%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

Contact details

Address:
Hauptstrasse 144
BUBENDORF
4416
Switzerland
Telephone:
+41 (61) 9352333
Website:
www.bachem.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BANB
ISIN:
CH0012530207
Market cap:
5.13 billion CHF
Shares in issue:
14.75 million
Sector:
Life Sciences Tools & Services
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
n/a

Key personnel

  • Thomas Meier
    Chief Executive Officer, Chairman of the Corporate Executive Committee
  • Stephan Schindler
    Chief Financial Officer, Member of the Corporate Executive Committee
  • Roland Schuermann
    Chief Operating Officer, Member of the Corporate Executive Committee
  • Gunther Loidl
    Chief Technology Officer, Member of the Corporate Executive Committee
  • Anne-Kathrin Stoller
    Chief Marketing Officer, Member of the Corporate Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.